 | • レポートコード：QAF27918 • 出版社/出版日：QYResearch / 2021年4月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の結核ワクチン治療市場について種類別（免疫ワクチン、治療ワクチン）、用途別（自己調達、ユニセフ、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・結核ワクチン治療市場の概要 ・世界の主要地域別結核ワクチン治療市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の結核ワクチン治療市場規模2016-2021：種類別（免疫ワクチン、治療ワクチン） ・世界の結核ワクチン治療市場予測2012-2027：種類別（免疫ワクチン、治療ワクチン） ・世界の結核ワクチン治療市場規模2016-2021：用途別（自己調達、ユニセフ、その他） ・世界の結核ワクチン治療市場予測2012-2027：用途別（自己調達、ユニセフ、その他） ・結核ワクチン治療のアメリカ市場規模と予測2016-2021 ・結核ワクチン治療のヨーロッパ市場規模と予測2016-2021 ・結核ワクチン治療の中国市場規模と予測2016-2021 ・結核ワクチン治療の日本市場規模と予測2016-2021 ・結核ワクチン治療の東南アジア市場規模と予測2016-2021 ・結核ワクチン治療のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Merck、Japan BCG Lab、Serum Institute of India、AJ Vaccines、BioFarma、GreenSignal Bio Pharma、China National Biotec、Biomed Lublin、Taj Pharmaceuticals、Ataulpho de Paiva、IVAC、Queen Saovabha Mem. Inst、Microgen） ・結核ワクチン治療の製造コスト分析 ・販売チャネル、流通業者、顧客 ・結核ワクチン治療の市場動向・機会・課題 ・調査の結論 |
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.
The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.
Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.
Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.
Market Analysis and Insights: Global Tuberculosis Vaccine Treatment Market
The global Tuberculosis Vaccine Treatment market was valued at US$ 74 in 2020 and will reach US$ 87 million by the end of 2027, growing at a CAGR of 2.9% during 2022-2027.
Global Tuberculosis Vaccine Treatment Scope and Market Size
The global Tuberculosis Vaccine Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Vaccine Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Immune Vaccine
Therapy Vaccine
Segment by Application
Self-Procurement
UNICEF
Other
The Tuberculosis Vaccine Treatment market is analysed and market size information is provided by regions (countries). Segment by Application, the Tuberculosis Vaccine Treatment market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
1 Tuberculosis Vaccine Treatment Market Overview
1.1 Tuberculosis Vaccine Treatment Product Scope
1.2 Tuberculosis Vaccine Treatment Segment by Type
1.2.1 Global Tuberculosis Vaccine Treatment Sales by Type (2016 & 2021 & 2027)
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Tuberculosis Vaccine Treatment Segment by Application
1.3.1 Global Tuberculosis Vaccine Treatment Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Tuberculosis Vaccine Treatment Market Estimates and Forecasts (2016-2027)
1.4.1 Global Tuberculosis Vaccine Treatment Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Tuberculosis Vaccine Treatment Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Tuberculosis Vaccine Treatment Price Trends (2016-2027)
2 Tuberculosis Vaccine Treatment Estimates and Forecasts by Region
2.1 Global Tuberculosis Vaccine Treatment Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Tuberculosis Vaccine Treatment Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2021)
2.2.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2016-2021)
2.3 Global Tuberculosis Vaccine Treatment Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Tuberculosis Vaccine Treatment Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Tuberculosis Vaccine Treatment Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Tuberculosis Vaccine Treatment Estimates and Projections (2016-2027)
2.4.2 Europe Tuberculosis Vaccine Treatment Estimates and Projections (2016-2027)
2.4.3 China Tuberculosis Vaccine Treatment Estimates and Projections (2016-2027)
2.4.4 Japan Tuberculosis Vaccine Treatment Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Tuberculosis Vaccine Treatment Estimates and Projections (2016-2027)
2.4.6 India Tuberculosis Vaccine Treatment Estimates and Projections (2016-2027)
3 Global Tuberculosis Vaccine Treatment Competition Landscape by Players
3.1 Global Top Tuberculosis Vaccine Treatment Players by Sales (2016-2021)
3.2 Global Top Tuberculosis Vaccine Treatment Players by Revenue (2016-2021)
3.3 Global Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis Vaccine Treatment as of 2020)
3.4 Global Tuberculosis Vaccine Treatment Average Price by Company (2016-2021)
3.5 Manufacturers Tuberculosis Vaccine Treatment Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Tuberculosis Vaccine Treatment Market Size by Type
4.1 Global Tuberculosis Vaccine Treatment Historic Market Review by Type (2016-2021)
4.1.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
4.1.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2016-2021)
4.1.3 Global Tuberculosis Vaccine Treatment Price by Type (2016-2021)
4.2 Global Tuberculosis Vaccine Treatment Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Tuberculosis Vaccine Treatment Sales Forecast by Type (2022-2027)
4.2.2 Global Tuberculosis Vaccine Treatment Revenue Forecast by Type (2022-2027)
4.2.3 Global Tuberculosis Vaccine Treatment Price Forecast by Type (2022-2027)
5 Global Tuberculosis Vaccine Treatment Market Size by Application
5.1 Global Tuberculosis Vaccine Treatment Historic Market Review by Application (2016-2021)
5.1.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
5.1.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2016-2021)
5.1.3 Global Tuberculosis Vaccine Treatment Price by Application (2016-2021)
5.2 Global Tuberculosis Vaccine Treatment Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Tuberculosis Vaccine Treatment Sales Forecast by Application (2022-2027)
5.2.2 Global Tuberculosis Vaccine Treatment Revenue Forecast by Application (2022-2027)
5.2.3 Global Tuberculosis Vaccine Treatment Price Forecast by Application (2022-2027)
6 North America Tuberculosis Vaccine Treatment Market Facts & Figures
6.1 North America Tuberculosis Vaccine Treatment Sales by Company
6.1.1 North America Tuberculosis Vaccine Treatment Sales by Company (2016-2021)
6.1.2 North America Tuberculosis Vaccine Treatment Revenue by Company (2016-2021)
6.2 North America Tuberculosis Vaccine Treatment Sales Breakdown by Type
6.2.1 North America Tuberculosis Vaccine Treatment Sales Breakdown by Type (2016-2021)
6.2.2 North America Tuberculosis Vaccine Treatment Sales Breakdown by Type (2022-2027)
6.3 North America Tuberculosis Vaccine Treatment Sales Breakdown by Application
6.3.1 North America Tuberculosis Vaccine Treatment Sales Breakdown by Application (2016-2021)
6.3.2 North America Tuberculosis Vaccine Treatment Sales Breakdown by Application (2022-2027)
7 Europe Tuberculosis Vaccine Treatment Market Facts & Figures
7.1 Europe Tuberculosis Vaccine Treatment Sales by Company
7.1.1 Europe Tuberculosis Vaccine Treatment Sales by Company (2016-2021)
7.1.2 Europe Tuberculosis Vaccine Treatment Revenue by Company (2016-2021)
7.2 Europe Tuberculosis Vaccine Treatment Sales Breakdown by Type
7.2.1 Europe Tuberculosis Vaccine Treatment Sales Breakdown by Type (2016-2021)
7.2.2 Europe Tuberculosis Vaccine Treatment Sales Breakdown by Type (2022-2027)
7.3 Europe Tuberculosis Vaccine Treatment Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Tuberculosis Vaccine Treatment Market Facts & Figures
8.1 China Tuberculosis Vaccine Treatment Sales by Company
8.1.1 China Tuberculosis Vaccine Treatment Sales by Company (2016-2021)
8.1.2 China Tuberculosis Vaccine Treatment Revenue by Company (2016-2021)
8.2 China Tuberculosis Vaccine Treatment Sales Breakdown by Type
8.2.1 China Tuberculosis Vaccine Treatment Sales Breakdown by Type (2016-2021)
8.2.2 China Tuberculosis Vaccine Treatment Sales Breakdown by Type (2022-2027)
8.3 China Tuberculosis Vaccine Treatment Sales Breakdown by Application
8.3.1 China 315 Sales Breakdown by Application (2016-2021)
8.3.2 China 315 Sales Breakdown by Application (2022-2027)
9 Japan Tuberculosis Vaccine Treatment Market Facts & Figures
9.1 Japan Tuberculosis Vaccine Treatment Sales by Company
9.1.1 Japan Tuberculosis Vaccine Treatment Sales by Company (2016-2021)
9.1.2 Japan Tuberculosis Vaccine Treatment Revenue by Company (2016-2021)
9.2 Japan Tuberculosis Vaccine Treatment Sales Breakdown by Type
9.2.1 Japan Tuberculosis Vaccine Treatment Sales Breakdown by Type (2016-2021)
9.2.2 Japan Tuberculosis Vaccine Treatment Sales Breakdown by Type (2022-2027)
9.3 Japan Tuberculosis Vaccine Treatment Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Tuberculosis Vaccine Treatment Market Facts & Figures
10.1 Southeast Asia Tuberculosis Vaccine Treatment Sales by Company
10.1.1 Southeast Asia Tuberculosis Vaccine Treatment Sales by Company (2016-2021)
10.1.2 Southeast Asia Tuberculosis Vaccine Treatment Revenue by Company (2016-2021)
10.2 Southeast Asia Tuberculosis Vaccine Treatment Sales Breakdown by Type
10.2.1 Southeast Asia Tuberculosis Vaccine Treatment Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Tuberculosis Vaccine Treatment Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Tuberculosis Vaccine Treatment Sales Breakdown by Application
10.3.1 Southeast Asia K Dose Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Dose Sales Breakdown by Application (2022-2027)
11 India Tuberculosis Vaccine Treatment Market Facts & Figures
11.1 India Tuberculosis Vaccine Treatment Sales by Company
11.1.1 India Tuberculosis Vaccine Treatment Sales by Company (2016-2021)
11.1.2 India Tuberculosis Vaccine Treatment Revenue by Company (2016-2021)
11.2 India Tuberculosis Vaccine Treatment Sales Breakdown by Type
11.2.1 India Tuberculosis Vaccine Treatment Sales Breakdown by Type (2016-2021)
11.2.2 India Tuberculosis Vaccine Treatment Sales Breakdown by Type (2022-2027)
11.3 India Tuberculosis Vaccine Treatment Sales Breakdown by Application
11.3.1 India Tuberculosis Vaccine Treatment Sales Breakdown by Application (2016-2021)
11.3.2 India Tuberculosis Vaccine Treatment Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Tuberculosis Vaccine Treatment Business
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Business Overview
12.1.3 Merck Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Tuberculosis Vaccine Treatment Products Offered
12.1.5 Merck Recent Development
12.2 Japan BCG Lab
12.2.1 Japan BCG Lab Corporation Information
12.2.2 Japan BCG Lab Business Overview
12.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Products Offered
12.2.5 Japan BCG Lab Recent Development
12.3 Serum Institute of India
12.3.1 Serum Institute of India Corporation Information
12.3.2 Serum Institute of India Business Overview
12.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Products Offered
12.3.5 Serum Institute of India Recent Development
12.4 AJ Vaccines
12.4.1 AJ Vaccines Corporation Information
12.4.2 AJ Vaccines Business Overview
12.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
12.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Products Offered
12.4.5 AJ Vaccines Recent Development
12.5 BioFarma
12.5.1 BioFarma Corporation Information
12.5.2 BioFarma Business Overview
12.5.3 BioFarma Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
12.5.4 BioFarma Tuberculosis Vaccine Treatment Products Offered
12.5.5 BioFarma Recent Development
12.6 GreenSignal Bio Pharma
12.6.1 GreenSignal Bio Pharma Corporation Information
12.6.2 GreenSignal Bio Pharma Business Overview
12.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
12.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Products Offered
12.6.5 GreenSignal Bio Pharma Recent Development
12.7 China National Biotec
12.7.1 China National Biotec Corporation Information
12.7.2 China National Biotec Business Overview
12.7.3 China National Biotec Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
12.7.4 China National Biotec Tuberculosis Vaccine Treatment Products Offered
12.7.5 China National Biotec Recent Development
12.8 Biomed Lublin
12.8.1 Biomed Lublin Corporation Information
12.8.2 Biomed Lublin Business Overview
12.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Products Offered
12.8.5 Biomed Lublin Recent Development
12.9 Taj Pharmaceuticals
12.9.1 Taj Pharmaceuticals Corporation Information
12.9.2 Taj Pharmaceuticals Business Overview
12.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Products Offered
12.9.5 Taj Pharmaceuticals Recent Development
12.10 Ataulpho de Paiva
12.10.1 Ataulpho de Paiva Corporation Information
12.10.2 Ataulpho de Paiva Business Overview
12.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Products Offered
12.10.5 Ataulpho de Paiva Recent Development
12.11 IVAC
12.11.1 IVAC Corporation Information
12.11.2 IVAC Business Overview
12.11.3 IVAC Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
12.11.4 IVAC Tuberculosis Vaccine Treatment Products Offered
12.11.5 IVAC Recent Development
12.12 Queen Saovabha Mem. Inst
12.12.1 Queen Saovabha Mem. Inst Corporation Information
12.12.2 Queen Saovabha Mem. Inst Business Overview
12.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Products Offered
12.12.5 Queen Saovabha Mem. Inst Recent Development
12.13 Microgen
12.13.1 Microgen Corporation Information
12.13.2 Microgen Business Overview
12.13.3 Microgen Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Microgen Tuberculosis Vaccine Treatment Products Offered
12.13.5 Microgen Recent Development
13 Tuberculosis Vaccine Treatment Manufacturing Cost Analysis
13.1 Tuberculosis Vaccine Treatment Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Tuberculosis Vaccine Treatment
13.4 Tuberculosis Vaccine Treatment Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Tuberculosis Vaccine Treatment Distributors List
14.3 Tuberculosis Vaccine Treatment Customers
15 Market Dynamics
15.1 Tuberculosis Vaccine Treatment Market Trends
15.2 Tuberculosis Vaccine Treatment Drivers
15.3 Tuberculosis Vaccine Treatment Market Challenges
15.4 Tuberculosis Vaccine Treatment Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Tuberculosis Vaccine Treatment Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Tuberculosis Vaccine Treatment Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Tuberculosis Vaccine Treatment Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Tuberculosis Vaccine Treatment Sales (K Dose) by Region (2016-2021)
Table 5. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2021)
Table 6. Global Tuberculosis Vaccine Treatment Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Tuberculosis Vaccine Treatment Revenue Share by Region (2016-2021)
Table 8. Global Tuberculosis Vaccine Treatment Sales (K Dose) Forecast by Region (2022-2027)
Table 9. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Tuberculosis Vaccine Treatment Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Tuberculosis Vaccine Treatment Revenue Share Forecast by Region (2022-2027)
Table 12. Global Tuberculosis Vaccine Treatment Sales (K Dose) of Key Companies (2016-2021)
Table 13. Global Tuberculosis Vaccine Treatment Sales Share by Company (2016-2021)
Table 14. Global Tuberculosis Vaccine Treatment Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Tuberculosis Vaccine Treatment Revenue Share by Company (2016-2021)
Table 16. Global Tuberculosis Vaccine Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Vaccine Treatment as of 2020)
Table 17. Global Tuberculosis Vaccine Treatment Average Price (USD/K Dose) of Key Company (2016-2021)
Table 18. Manufacturers Tuberculosis Vaccine Treatment Manufacturing Sites and Area Served
Table 19. Manufacturers Tuberculosis Vaccine Treatment Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Tuberculosis Vaccine Treatment Sales (K Dose) by Type (2016-2021)
Table 22. Global Tuberculosis Vaccine Treatment Sales Share by Type (2016-2021)
Table 23. Global Tuberculosis Vaccine Treatment Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Tuberculosis Vaccine Treatment Price (USD/K Dose) by Type (2016-2021)
Table 25. Global Tuberculosis Vaccine Treatment Sales Share by Type (2022-2027)
Table 26. Global Tuberculosis Vaccine Treatment Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Tuberculosis Vaccine Treatment Revenue Share by Type (2022-2027)
Table 28. Global Tuberculosis Vaccine Treatment Price (USD/K Dose) by Type (2022-2027)
Table 29. Global Tuberculosis Vaccine Treatment Sales (K Dose) by Application (2016-2021)
Table 30. Global Tuberculosis Vaccine Treatment Sales Share by Application (2016-2021)
Table 31. Global Tuberculosis Vaccine Treatment Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Tuberculosis Vaccine Treatment Price (USD/K Dose) by Application (2016-2021)
Table 33. Global Tuberculosis Vaccine Treatment Sales (K Dose) by Application (2022-2027)
Table 34. Global Tuberculosis Vaccine Treatment Sales Share by Application (2022-2027)
Table 35. Global Tuberculosis Vaccine Treatment Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Tuberculosis Vaccine Treatment Revenue Share by Application (2022-2027)
Table 37. Global Tuberculosis Vaccine Treatment Price (USD/K Dose) by Application (2022-2027)
Table 38. North America Tuberculosis Vaccine Treatment Sales (K Dose) by Company (2016-2021)
Table 39. North America Tuberculosis Vaccine Treatment Sales Market Share by Company (2016-2021)
Table 40. North America Tuberculosis Vaccine Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Tuberculosis Vaccine Treatment Revenue Market Share by Company (2016-2021)
Table 42. North America Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
Table 43. North America Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
Table 44. North America Tuberculosis Vaccine Treatment Sales by Type (2022-2027) & (K Dose)
Table 45. North America Tuberculosis Vaccine Treatment Sales Market Share by Type (2022-2027)
Table 46. North America Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
Table 47. North America Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
Table 48. North America Tuberculosis Vaccine Treatment Sales by Application (2022-2027) & (K Dose)
Table 49. North America Tuberculosis Vaccine Treatment Sales Market Share by Application (2022-2027)
Table 50. Europe Tuberculosis Vaccine Treatment Sales (K Dose) by Company (2016-2021)
Table 51. Europe Tuberculosis Vaccine Treatment Sales Market Share by Company (2016-2021)
Table 52. Europe Tuberculosis Vaccine Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Company (2016-2021)
Table 54. Europe Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
Table 55. Europe Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
Table 56. Europe Tuberculosis Vaccine Treatment Sales by Type (2022-2027) & (K Dose)
Table 57. Europe Tuberculosis Vaccine Treatment Sales Market Share by Type (2022-2027)
Table 58. Europe Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
Table 59. Europe Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
Table 60. Europe Tuberculosis Vaccine Treatment Sales by Application (2022-2027) & (K Dose)
Table 61. Europe Tuberculosis Vaccine Treatment Sales Market Share by Application (2022-2027)
Table 62. China Tuberculosis Vaccine Treatment Sales (K Dose) by Company (2016-2021)
Table 63. China Tuberculosis Vaccine Treatment Sales Market Share by Company (2016-2021)
Table 64. China Tuberculosis Vaccine Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Tuberculosis Vaccine Treatment Revenue Market Share by Company (2016-2021)
Table 66. China Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
Table 67. China Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
Table 68. China Tuberculosis Vaccine Treatment Sales by Type (2022-2027) & (K Dose)
Table 69. China Tuberculosis Vaccine Treatment Sales Market Share by Type (2022-2027)
Table 70. China Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
Table 71. China Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
Table 72. China Tuberculosis Vaccine Treatment Sales by Application (2022-2027) & (K Dose)
Table 73. China Tuberculosis Vaccine Treatment Sales Market Share by Application (2022-2027)
Table 74. Japan Tuberculosis Vaccine Treatment Sales (K Dose) by Company (2016-2021)
Table 75. Japan Tuberculosis Vaccine Treatment Sales Market Share by Company (2016-2021)
Table 76. Japan Tuberculosis Vaccine Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Tuberculosis Vaccine Treatment Revenue Market Share by Company (2016-2021)
Table 78. Japan Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
Table 79. Japan Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
Table 80. Japan Tuberculosis Vaccine Treatment Sales by Type (2022-2027) & (K Dose)
Table 81. Japan Tuberculosis Vaccine Treatment Sales Market Share by Type (2022-2027)
Table 82. Japan Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
Table 83. Japan Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
Table 84. Japan Tuberculosis Vaccine Treatment Sales by Application (2022-2027) & (K Dose)
Table 85. Japan Tuberculosis Vaccine Treatment Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Tuberculosis Vaccine Treatment Sales (K Dose) by Company (2016-2021)
Table 87. Southeast Asia Tuberculosis Vaccine Treatment Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Tuberculosis Vaccine Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Tuberculosis Vaccine Treatment Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
Table 91. Southeast Asia Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Tuberculosis Vaccine Treatment Sales by Type (2022-2027) & (K Dose)
Table 93. Southeast Asia Tuberculosis Vaccine Treatment Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
Table 95. Southeast Asia Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Tuberculosis Vaccine Treatment Sales by Application (2022-2027) & (K Dose)
Table 97. Southeast Asia Tuberculosis Vaccine Treatment Sales Market Share by Application (2022-2027)
Table 98. India Tuberculosis Vaccine Treatment Sales (K Dose) by Company (2016-2021)
Table 99. India Tuberculosis Vaccine Treatment Sales Market Share by Company (2016-2021)
Table 100. India Tuberculosis Vaccine Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Tuberculosis Vaccine Treatment Revenue Market Share by Company (2016-2021)
Table 102. India Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
Table 103. India Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
Table 104. India Tuberculosis Vaccine Treatment Sales by Type (2022-2027) & (K Dose)
Table 105. India Tuberculosis Vaccine Treatment Sales Market Share by Type (2022-2027)
Table 106. India Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
Table 107. India Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
Table 108. India Tuberculosis Vaccine Treatment Sales by Application (2022-2027) & (K Dose)
Table 109. India Tuberculosis Vaccine Treatment Sales Market Share by Application (2022-2027)
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 113. Merck Tuberculosis Vaccine Treatment Product
Table 114. Merck Recent Development
Table 115. Japan BCG Lab Corporation Information
Table 116. Japan BCG Lab Description and Business Overview
Table 117. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 118. Japan BCG Lab Tuberculosis Vaccine Treatment Product
Table 119. Japan BCG Lab Recent Development
Table 120. Serum Institute of India Corporation Information
Table 121. Serum Institute of India Description and Business Overview
Table 122. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 123. Serum Institute of India Tuberculosis Vaccine Treatment Product
Table 124. Serum Institute of India Recent Development
Table 125. AJ Vaccines Corporation Information
Table 126. AJ Vaccines Description and Business Overview
Table 127. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 128. AJ Vaccines Tuberculosis Vaccine Treatment Product
Table 129. AJ Vaccines Recent Development
Table 130. BioFarma Corporation Information
Table 131. BioFarma Description and Business Overview
Table 132. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 133. BioFarma Tuberculosis Vaccine Treatment Product
Table 134. BioFarma Recent Development
Table 135. GreenSignal Bio Pharma Corporation Information
Table 136. GreenSignal Bio Pharma Description and Business Overview
Table 137. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 138. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product
Table 139. GreenSignal Bio Pharma Recent Development
Table 140. China National Biotec Corporation Information
Table 141. China National Biotec Description and Business Overview
Table 142. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 143. China National Biotec Tuberculosis Vaccine Treatment Product
Table 144. China National Biotec Recent Development
Table 145. Biomed Lublin Corporation Information
Table 146. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 147. Biomed Lublin Description and Business Overview
Table 148. Biomed Lublin Tuberculosis Vaccine Treatment Product
Table 149. Biomed Lublin Recent Development
Table 150. Taj Pharmaceuticals Corporation Information
Table 151. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 152. Taj Pharmaceuticals Description and Business Overview
Table 153. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product
Table 154. Taj Pharmaceuticals Recent Development
Table 155. Ataulpho de Paiva Corporation Information
Table 156. Ataulpho de Paiva Description and Business Overview
Table 157. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 158. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product
Table 159. Ataulpho de Paiva Recent Development
Table 160. IVAC Corporation Information
Table 161. IVAC Description and Business Overview
Table 162. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 163. IVAC Tuberculosis Vaccine Treatment Product
Table 164. IVAC Recent Development
Table 165. Queen Saovabha Mem. Inst Corporation Information
Table 166. Queen Saovabha Mem. Inst Description and Business Overview
Table 167. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 168. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product
Table 169. Queen Saovabha Mem. Inst Recent Development
Table 170. Microgen Corporation Information
Table 171. Microgen Description and Business Overview
Table 172. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2016-2021)
Table 173. Microgen Tuberculosis Vaccine Treatment Product
Table 174. Microgen Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Tuberculosis Vaccine Treatment Distributors List
Table 178. Tuberculosis Vaccine Treatment Customers List
Table 179. Tuberculosis Vaccine Treatment Market Trends
Table 180. Tuberculosis Vaccine Treatment Market Drivers
Table 181. Tuberculosis Vaccine Treatment Market Challenges
Table 182. Tuberculosis Vaccine Treatment Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis Vaccine Treatment Product Picture
Figure 2. Global Tuberculosis Vaccine Treatment Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Tuberculosis Vaccine Treatment Sales Market Share by Application in 2021 & 2027
Figure 6. Self-Procurement Examples
Figure 7. UNICEF Examples
Figure 8. Other Examples
Figure 9. Global Tuberculosis Vaccine Treatment Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Tuberculosis Vaccine Treatment Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Tuberculosis Vaccine Treatment Sales (K Dose) Growth Rate (2016-2027)
Figure 12. Global Tuberculosis Vaccine Treatment Price Trends Growth Rate (2016-2027) (USD/K Dose)
Figure 13. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Tuberculosis Vaccine Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Tuberculosis Vaccine Treatment Sales (K Dose) Growth Rate (2016-2027)
Figure 17. Europe Tuberculosis Vaccine Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Tuberculosis Vaccine Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Tuberculosis Vaccine Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Tuberculosis Vaccine Treatment Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Tuberculosis Vaccine Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Tuberculosis Vaccine Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Tuberculosis Vaccine Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Tuberculosis Vaccine Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Tuberculosis Vaccine Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Tuberculosis Vaccine Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Tuberculosis Vaccine Treatment Players Market Share by Revenue in Tuberculosis Vaccine Treatment: 2016 & 2020
Figure 28. Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Tuberculosis Vaccine Treatment Revenue Share by Type (2016-2021)
Figure 30. Global Tuberculosis Vaccine Treatment Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Tuberculosis Vaccine Treatment Revenue Share by Application (2016-2021)
Figure 32. Global Tuberculosis Vaccine Treatment Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020
Figure 34. North America Tuberculosis Vaccine Treatment Sales Market Share by Application in 2020
Figure 35. Europe Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020
Figure 36. Europe Tuberculosis Vaccine Treatment Sales Market Share by Application in 2020
Figure 37. China Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020
Figure 38. China Tuberculosis Vaccine Treatment Sales Market Share by Application in 2020
Figure 39. Japan Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020
Figure 40. Japan Tuberculosis Vaccine Treatment Sales Market Share by Application in 2020
Figure 41. Southeast Asia Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020
Figure 42. Southeast Asia Tuberculosis Vaccine Treatment Sales Market Share by Application in 2020
Figure 43. India Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020
Figure 44. India Tuberculosis Vaccine Treatment Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Tuberculosis Vaccine Treatment
Figure 47. Manufacturing Process Analysis of Tuberculosis Vaccine Treatment
Figure 48. Tuberculosis Vaccine Treatment Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界の結核（TB）治療市場規模・現状・予測（2021年-2027年） If you have latent tuberculosis, you may need to take only one or two types of TB drug. Active tuberculosis, particularly if it's a drug-resistant strain, will require several drugs at once. The most common medications used to treat tuberculosis include: Isoniazid Rifampin (Rifadin, Rimactane) Etham…- 世界の結核診断＆治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tuberculosis Diagnostics and Treatment Market The global Tuberculosis Diagnostics and Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…
- 世界の結核分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing tuberculosis Market Analysis and Insights: Global Molecular Diagnosis of Tuberculosis Market The global Molecular Diagnosis of Tuberculosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. Wi…
- 世界の結核菌検査市場規模・現状・予測（2021年-2027年） Tuberculosis is an infectious disease caused by mycobacterium tuberculosis and mainly affects the lungs. Market Analysis and Insights: Global Mycobacterium Tuberculosis Testing Market The global Mycobacterium Tuberculosis Testing market size is projected to reach US$ XX million by 2027, from US$ XX …
- 世界の髄膜炎菌感染症ワクチン市場規模・現状・予測（2021年-2027年） Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in…